Tokyo Tape
Sign in
← Takeda Pharmaceutical

Quarterly report · Q3

4502.TEDINET S100Q2VA
Period2022-04-01 → 2022-12-31
Filed2023-02-07
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥3.07T2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥1.10T2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥3.57T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.70T2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥901.3bn2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income¥401.9bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥147.0bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥462.5bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥116.5bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥327.2bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥107.2bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥302.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥356.6bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥72.2bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥285.9bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥119.1bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥230.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥241.4bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥57.8bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥285.9bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥119.1bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥230.2bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥241.5bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥57.8bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥13.50Tat 2022-12-31Cons.Assets IFRS
Total assets¥13.18Tat 2022-03-31Cons.Assets IFRS
Total assets¥12.70Tat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥7.33Tat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥7.49Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥6.18Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥5.68Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥5.33Tat 2021-12-31Cons.Equity IFRS
Net assets / equity¥5.18Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥6.18Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥5.68Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥685.1bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥849.7bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥724.3bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥966.2bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥683.5bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.12T2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥747.5bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥168.6bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥198.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥172.5bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥702.5bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.07T2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥826.5bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥184.322022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥76.632022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥147.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥154.092021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥36.912021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥182.652022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥75.862022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥145.872021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥153.032021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥36.682021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio45.7%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.1%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.0%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 711
ItemContextValueUnit
Dividends ss IFRSCurrentYTDDuration-278321000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-12977000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-22402000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration－JPY
Share based compensation ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Share based compensation ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember45823000000JPY
Share based compensation ss IFRSCurrentYTDDuration45823000000JPY
Exercise of share based awards ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Exercise of share based awards ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember22000000JPY
Exercise of share based awards ss IFRSCurrentYTDDuration22000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_jpcrp040300-q3r_E00919-000HedgingCostIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-12977000000JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-22402000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-259395000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration-259395000000JPY
Equity IFRSCurrentQuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember-83486000000JPY
Equity IFRSCurrentQuarterInstant_jpcrp040300-q3r_E00919-000HedgingCostIFRSMember-18242000000JPY
Equity IFRSCurrentQuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember1380202000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember6175978000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember520000000JPY
Equity IFRSCurrentQuarterInstant6176498000000JPY
Profit loss IFRSPrior1YTDDuration241541000000JPY
Profit loss IFRSCurrentYTDDuration285903000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration430877000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration502990000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration14666000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration41969000000JPY
Share based payment expenses ope cf IFRSPrior1YTDDuration32057000000JPY
Share based payment expenses ope cf IFRSCurrentYTDDuration45823000000JPY
Loss gain on disposal and sale of property plant and equipment ope cf IFRSPrior1YTDDuration258000000JPY
Loss gain on disposal and sale of property plant and equipment ope cf IFRSCurrentYTDDuration-161000000JPY
Gain on sale of businesses ope cf IFRSPrior1YTDDuration-1095000000JPY
Gain on sale of businesses ope cf IFRSCurrentYTDDuration-959000000JPY
Change in fair value of financial assets and liabilities associated with contingent consideration arrangements net ope cf IFRSPrior1YTDDuration-9683000000JPY
Change in fair value of financial assets and liabilities associated with contingent consideration arrangements net ope cf IFRSCurrentYTDDuration4323000000JPY
Finance income and finance costs ope cf IFRSPrior1YTDDuration100589000000JPY
Finance income and finance costs ope cf IFRSCurrentYTDDuration71635000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration5255000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration3133000000JPY
Income tax expense ope cf IFRSPrior1YTDDuration115077000000JPY
Income tax expense ope cf IFRSCurrentYTDDuration41273000000JPY
Decrease increase in trade and other receivables2 ope cf IFRSPrior1YTDDuration82243000000JPY
Decrease increase in trade and other receivables2 ope cf IFRSCurrentYTDDuration6856000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-39268000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-34240000000JPY
Increase decrease in trade and other payables2 ope cf IFRSPrior1YTDDuration-1797000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass